InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by MacDougall Ann L., Director. Director active across 1 company, notably Opiant Pharmaceuticals, INC.. Aggregated, 7 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €32k. Activity tracked since 13 May 2021. The latest transaction was filed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
26,179 shares@ US$20.0092.9% of flowCommon StockSEC:0001385508-23-000061:0
2,000 shares0Common StockSEC:0001385508-22-000084:0
3,000 shares@ US$10.92684.8% of flowCommon StockSEC:0001385508-22-000057:0
Ideal exit: 7 Feb 2023 (T+270)
2,000 shares0Common StockSEC:0001385508-21-000086
2,000 shares0Common StockSEC:0001385508-21-000086:0
341 shares@ US$10.007.6% of flowCommon StockSEC:0001385508-21-000070:0
341 shares@ US$10.007.6% of flowCommon StockSEC:0001385508-21-000070
7 of 7 declarations
About MacDougall Ann L.
Ann L. MacDougall is a Board Member at OPIANT PHARMACEUTICALS, INC., a biopharmaceutical company. As a board member, she participates in the strategy and management of the company. Her expertise in the pharmaceutical sector is an asset for Opiant.
